November 16 from 1:30 pm – 2:15 pm EST
Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.
Program Description
Please join expert rheumatologist Rodney Daniel, MD and pulmonologist Steve Nathan, MD as they discuss the signs and symptoms of autoimmune-associated ILD, the diagnostic process, and the importance of collaboration from a combined rheumatologist/pulmonologist perspective. They will also engage in a conversation with patient mentor Amy who will share her personal ILD journey. This presentation is made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc.
This program is developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc. This is not an official program of the American College of Rheumatology. This session will be conducted during ACR Convergence 2024.
This is a non-CME event and does not qualify for CME, CE, or MOC credit. This presentation is open to all ACR Convergence 2024 attendees. Onsite registration will occur for conference registrants only at the program entrance on a first-come, first-served basis. This presentation is sponsored by and made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc. Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.
Speakers:
Rodney Daniel, MD
Bay Area Rheumatology
Rheumatologist
Oldsmar, Florida
Steve Nathan, MD
Inova Fairfax Hospital
Advanced Lung Disease and Transplant Program
Medical Director
Falls Church, Virginia